By Rick Archer (January 25, 2022, 7:18 PM EST) – Drugmaker Mallinckrodt PLC is asking a Delaware bankruptcy judge to approve a $13.9 million settlement with a subsidiary of German pharmaceutical company Fresenius Kabi to end a dispute over supply payments. Mallinckrodt cut off when he entered Chapter 11.
In a motion filed Monday, Mallinckrodt said the settlement would resolve about $16.5 million of claims Fresenius had asserted in the case in exchange for less than $1 million in priority payments and a tranche of the fund. trustee of unsecured creditors.
According to filings, Mallinckrodt and Fresenius’ Norwegian subsidiary, Fresenius Kabi Norge, had a contract under which Mallinckrodt agreed to purchase…
Stay one step ahead
In the legal profession, information is the key to success. You need to know what’s going on with customers, competitors, practice areas and industries. Law360 provides the intelligence you need to stay an expert and beat the competition.
Access to case data in articles (numbers, filings, courts, nature of lawsuits, etc.)
Access to attached documents such as briefs, motions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and more!